• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者呼吸困难评分、呼吸肌力量和肺功能的因素分析。

A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease.

作者信息

Mahler D A, Harver A

机构信息

Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire 03756.

出版信息

Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):467-70. doi: 10.1164/ajrccm/145.2_Pt_1.467.

DOI:10.1164/ajrccm/145.2_Pt_1.467
PMID:1736759
Abstract

The purpose of this study was to demonstrate that clinical ratings of dyspnea and physiologic function are separate dimensions underlying the pathophysiology of chronic obstructive pulmonary disease (COPD). We used principal-components factor analysis to confirm these dimensions using data collected prospectively in 86 symptomatic patients with COPD. Three different instruments were used to rate dyspnea: a modified Medical Research Council (MRC) scale, the oxygen cost diagram (OCD), and the baseline dyspnea index (BDI). Measures of physiologic function included standard spirometric measures (forced vital capacity [FVC] and forced expiratory volume in one second [FEV1]) and maximal inspiratory (PImax) and expiratory (PEmax) mouth pressures. Age of the 65 male and 21 female subjects was 62.9 +/- 1.2 yr (mean +/- SEM). All three clinical scales were significantly correlated with physiologic function (range of r values, 0.32 to 0.45; p less than 0.05), except for the relationship between the MRC scale and PEmax (r = -0.14; p = NS). The factor analysis yielded three factors that accounted for 71.9% of the total variance of the data: clinical ratings of dyspnea (MRC scale, OCD, and BDI) loaded on the first factor; maximal respiratory pressures and gender loaded on the second factor; and lung function and age loaded on the third factor. Additional post hoc factor analysis provided similar results when the sample was divided into two subgroups by randomization, by severity of dyspnea ratings, or by severity of airflow obstruction. We conclude that dyspnea ratings, maximal respiratory pressures, and lung function are separate factors or quantities that independently characterize the condition of patients with COPD.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

本研究的目的是证明呼吸困难的临床评分和生理功能是慢性阻塞性肺疾病(COPD)病理生理学的不同维度。我们使用主成分因子分析,利用前瞻性收集的86例有症状的COPD患者的数据来证实这些维度。使用三种不同的工具对呼吸困难进行评分:改良的医学研究委员会(MRC)量表、氧耗图(OCD)和基线呼吸困难指数(BDI)。生理功能的测量包括标准肺量计测量(用力肺活量[FVC]和一秒用力呼气量[FEV1])以及最大吸气(PImax)和呼气(PEmax)口腔压力。65名男性和21名女性受试者的年龄为62.9±1.2岁(均值±标准误)。除MRC量表与PEmax之间的关系外(r = -0.14;p =无统计学意义),所有三种临床量表均与生理功能显著相关(r值范围为0.32至0.45;p<0.05)。因子分析产生了三个因子,占数据总方差的71.9%:呼吸困难的临床评分(MRC量表、OCD和BDI)加载在第一个因子上;最大呼吸压力和性别加载在第二个因子上;肺功能和年龄加载在第三个因子上。当样本通过随机化、呼吸困难评分严重程度或气流阻塞严重程度分为两个亚组时,额外的事后因子分析提供了类似的结果。我们得出结论,呼吸困难评分、最大呼吸压力和肺功能是独立的因子或量,可独立表征COPD患者的病情。(摘要截断于250字)

相似文献

1
A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者呼吸困难评分、呼吸肌力量和肺功能的因素分析。
Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):467-70. doi: 10.1164/ajrccm/145.2_Pt_1.467.
2
Chronic exertional dyspnea and respiratory muscle function in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的慢性运动性呼吸困难与呼吸肌功能
Lung. 1997;175(5):311-9. doi: 10.1007/pl00007577.
3
Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease.呼吸困难和生理功能对慢性阻塞性肺疾病患者总体健康状况的影响。
Chest. 1992 Aug;102(2):395-401. doi: 10.1378/chest.102.2.395.
4
Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者呼吸困难评估临床方法分析
Am J Respir Crit Care Med. 1998 Oct;158(4):1185-9. doi: 10.1164/ajrccm.158.4.9802091.
5
Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD.重度慢性阻塞性肺疾病患者运动能力、呼吸困难评分及肺功能的因子分析
Eur Respir J. 1994 Apr;7(4):725-9. doi: 10.1183/09031936.94.07040725.
6
Changes in dyspnea, health status, and lung function in chronic airway disease.
Am J Respir Crit Care Med. 1995 Jan;151(1):61-5. doi: 10.1164/ajrccm.151.1.7812573.
7
Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.吸入性支气管扩张剂可减轻慢性阻塞性肺疾病患者运动期间的动态肺过度充气。
Am J Respir Crit Care Med. 1996 Mar;153(3):967-75. doi: 10.1164/ajrccm.153.3.8630581.
8
Effects of a simple prototype respiratory muscle trainer on respiratory muscle strength, quality of life and dyspnea, and oxidative stress in COPD patients: a preliminary study.一种简易原型呼吸肌训练器对慢性阻塞性肺疾病患者呼吸肌力量、生活质量、呼吸困难及氧化应激的影响:一项初步研究
Int J Chron Obstruct Pulmon Dis. 2017 May 12;12:1415-1425. doi: 10.2147/COPD.S131062. eCollection 2017.
9
Effect of obesity on respiratory mechanics during rest and exercise in COPD.肥胖对 COPD 患者静息和运动时呼吸力学的影响。
J Appl Physiol (1985). 2011 Jul;111(1):10-9. doi: 10.1152/japplphysiol.01131.2010. Epub 2011 Feb 24.
10
Physiologic correlates of dyspnea in patients with morbid obesity.病态肥胖患者呼吸困难的生理相关性
Int J Obes (Lond). 2007 Apr;31(4):700-6. doi: 10.1038/sj.ijo.0803460. Epub 2006 Sep 26.

引用本文的文献

1
Hierarchical stratification of the factors related to exertional dyspnoea and exercise intolerance in male COPD patients.男性 COPD 患者呼吸困难和运动不耐受相关因素的分层分析。
Ann Med. 2022 Dec;54(1):2941-2950. doi: 10.1080/07853890.2022.2135018.
2
Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches.结节病:治疗药物试验及新治疗方法的最新进展
Front Med (Lausanne). 2022 Oct 12;9:991783. doi: 10.3389/fmed.2022.991783. eCollection 2022.
3
Predictors of acute cardiovascular events following acute exacerbation period for patients with COPD: a nested case-control study.
COPD 急性加重期后发生急性心血管事件的预测因素:一项巢式病例对照研究。
BMC Cardiovasc Disord. 2020 Dec 10;20(1):518. doi: 10.1186/s12872-020-01803-8.
4
Pulmonary Function Influences the Performance of Berlin Questionnaire, Modified Berlin Questionnaire, and STOP-Bang Score for Screening Obstructive Sleep Apnea in Subjects with Chronic Obstructive Pulmonary Disease.肺功能影响 Berlin 问卷、改良 Berlin 问卷和 STOP-Bang 评分在 COPD 患者中筛查阻塞性睡眠呼吸暂停的性能。
Int J Chron Obstruct Pulmon Dis. 2020 May 29;15:1207-1216. doi: 10.2147/COPD.S248139. eCollection 2020.
5
Assessment Of Changes In Regional Xenon-Ventilation, Perfusion, And Ventilation-Perfusion Mismatch Using Dual-Energy Computed Tomography After Pharmacological Treatment In Patients With Chronic Obstructive Pulmonary Disease: Visual And Quantitative Analysis.采用双能 CT 对慢性阻塞性肺疾病患者药物治疗后区域性氙气通气、灌注和通气灌注不匹配的变化进行评估:视觉和定量分析。
Int J Chron Obstruct Pulmon Dis. 2019 Sep 25;14:2195-2203. doi: 10.2147/COPD.S210555. eCollection 2019.
6
Systematic review of the association between exercise tests and patient-reported outcomes in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者运动试验与患者报告结局之间关联的系统评价。
Int J Chron Obstruct Pulmon Dis. 2017 Aug 22;12:2487-2506. doi: 10.2147/COPD.S100204. eCollection 2017.
7
Systematic Review of the Association Between Laboratory- and Field-Based Exercise Tests and Lung Function in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者实验室和现场运动试验与肺功能关联的系统评价
Chronic Obstr Pulm Dis. 2015 Jul 8;2(4):321-342. doi: 10.15326/jcopdf.2.4.2014.0157.
8
Clinical assessment tests in evaluating patients with chronic obstructive pulmonary disease: A cross-sectional study.评估慢性阻塞性肺疾病患者的临床评估测试:一项横断面研究。
Medicine (Baltimore). 2016 Nov;95(47):e5471. doi: 10.1097/MD.0000000000005471.
9
Pharmacological treatment response according to the severity of symptoms in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者根据症状严重程度的药物治疗反应。
J Thorac Dis. 2015 Oct;7(10):1765-73. doi: 10.3978/j.issn.2072-1439.2015.10.27.
10
Prevalence, risk factors, and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan.台湾某社区医院慢性阻塞性肺疾病患者骨质疏松症的患病率、危险因素及健康相关生活质量
Int J Chron Obstruct Pulmon Dis. 2015 Jul 29;10:1493-500. doi: 10.2147/COPD.S85432. eCollection 2015.